Ascend Wellness Holdings, Inc.
Ascend Wellness Holdings, Inc. (AAWH): 16 pipeline candidates · ~15 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
15.4 months
D/E -12.38 · 0% dilution
N/A
16 candidates
N/A
N/A
A transparent, data-derived signal for Ascend Wellness Holdings, Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$109.6M
Cash
$60.9M
Quarterly Burn
$19.4M
Runway
15.4 mo
Revenue
$116.9M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (16 candidates)
Showing 10 of 16 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Sep 2024Institutional holders
1
Total value held
$14K
| Holder | Shares | Value |
|---|---|---|
| highpoint advisor group llc | 16,414 | $14K |
Frequently asked questions
How many drug candidates are in Ascend Wellness Holdings, Inc.'s pipeline?
Ascend Wellness Holdings, Inc. (AAWH) has 16 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Ascend Wellness Holdings, Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Ascend Wellness Holdings, Inc. has approximately 15.4 months of cash runway.
What is Ascend Wellness Holdings, Inc.'s market capitalization?
Ascend Wellness Holdings, Inc.'s market capitalization is approximately $109.6M.
Who is the CEO of Ascend Wellness Holdings, Inc.?
Mr. Samuel Brill is the chief executive officer of Ascend Wellness Holdings, Inc. (AAWH).
Get the full picture on Ascend Wellness Holdings, Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.